The January 2024 edition of MedNous is now out featuring a review of oncology drug approvals in 2023, quarterly stock market statistics, and the latest news about trans-Atlantic biopharma M&A. The current issue features an analysis of how medium-size privately owned European pharmas manage innovation and an interview with Calliditas Therapeutics of Sweden. For a complimentary copy please write to editor@evernow.eu.